Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2012
02/09/2012WO2012017083A1 Methods and products for production of wax esters
02/09/2012WO2012017069A1 Linker peptide and its use in fusion proteins
02/09/2012WO2012017067A1 Plants resistant to pathogens and methods for production thereof
02/09/2012WO2012016960A1 Genomics of actinoplanes utahensis
02/09/2012WO2012016445A1 Bacillus subtilis strain and uses thereof
02/09/2012WO2012016357A1 Microarray-based assay integrated with particles for analyzing molecular interactions
02/09/2012WO2012016315A1 A recombinant strain of the bacterium brucella spp and live vaccine against brucellosis
02/09/2012WO2011159758A3 Long lasting drug formulations
02/09/2012WO2011153430A3 Inhibiting striated muscle activator of rho signaling (stars) to improve glycemic control
02/09/2012WO2011147579A3 Fast screening of clones
02/09/2012WO2011138328A3 Use of inhibitory molecules for the treatment of pulmonary hypertension
02/09/2012WO2011108794A3 Gene regulating cytokinesis, plants transformed with the gene, and method for regulating growth of plants using same
02/09/2012WO2011103417A3 Vectors expressing hiv antigens and gm-csf and related methods for generating an immune response
02/09/2012WO2011103236A3 Personalized tumor biomarkers
02/09/2012WO2011079197A3 Regulatory polynucleotides and uses thereof
02/09/2012US20120036599 Novel fungal enzymes
02/09/2012US20120036598 Plants with improved morphogenesis and method of constructing the same
02/09/2012US20120036597 Cold-Tolerant Plants
02/09/2012US20120036596 Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases
02/09/2012US20120036595 Whole Seed Specific Promoter
02/09/2012US20120036594 RNA-Mediated Induction of Gene Expression in Plants
02/09/2012US20120036593 Plant Promoter Operable in Endosperm and Uses Thereof
02/09/2012US20120036591 Methods for mitochondrial dna replacement in oocytes
02/09/2012US20120036590 Interferon-like protein zcyto21
02/09/2012US20120036589 Vaccine
02/09/2012US20120036588 Method for observing gad67-positive cell in transgenic animal
02/09/2012US20120035354 Materials and methods for the modification of plant lignin content
02/09/2012US20120035248 Method for inhibiting the activity of mir-155
02/09/2012US20120035240 Conserved hbv and hcv sequences useful for gene silencing
02/09/2012US20120035100 Satiation peptide administration
02/09/2012US20120035083 Antireflective Coatings for High-Resolution Photolithographic Synthesis of DNA Array
02/09/2012US20120035079 Genotoxicity testing
02/09/2012US20120035077 Modified renilla luciferase nucleic acids and methods of use
02/09/2012US20120035073 Compositions and methods for the treatment of immune related diseases
02/09/2012US20120035065 Aptamer Regulated Nucleic Acids and Uses Thereof
02/09/2012US20120034698 Compositions and methods for increasing oil content in algae
02/09/2012US20120034693 Recombinant vector and use in gene therapy
02/09/2012US20120034691 Genetically encoded calcium indicators and methods of use
02/09/2012US20120034690 Cell lines producing blocking antibodies to human RANKL
02/09/2012US20120034689 Mycobacterial antigens expressed during latency
02/09/2012US20120034675 Tyrosinase mutant and methods of use thereof
02/09/2012US20120034673 Isolated plant deoxyhypusine synthase and nucleotides encoding same
02/09/2012US20120034672 Superluminescent luciferase variant with prolonged bioluminescence
02/09/2012US20120034661 Strains for the production of flavonoids from glucose
02/09/2012US20120034657 Thrombopoietic compounds
02/09/2012US20120034656 Neutralising Antibody Molecules Having Specificity for Human IL-17
02/09/2012US20120034655 Fsh producing cell clone
02/09/2012US20120034654 Method for transforming schizosaccharomyces pombe, transformant of schizosaccharomyces pombe and method for producing heterologous protein
02/09/2012US20120034653 Trophic Conversion of Obligate Phototrophic Algae Through Metabolic Engineering
02/09/2012US20120034652 Method for the Targeted Integration of Multiple Copies of a Gene of Interest in a Yarrowia Strain
02/09/2012US20120034651 Akt activity specifically inhibiting polypeptide
02/09/2012US20120034650 Nucleic acid molecule of a biosynthetic cluster encoding non ribosomal peptide synthases and uses thereof
02/09/2012US20120034643 Fluorescent protein
02/09/2012US20120034642 Method for obtaining a singular cell model capable of reproducing in vitro the metabolic idiosyncrasy of humans
02/09/2012US20120034630 Circovirus Sequences Associated With Piglet Weight Loss Disease (PWD)
02/09/2012US20120034299 Compositions for the treatment of gluten intolerance and uses thereof
02/09/2012US20120034261 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
02/09/2012US20120034257 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same
02/09/2012US20120034256 Hcv vaccines and methods for using the same
02/09/2012US20120034251 Pharmaceutical composition for treating or preventing cancer by inducing dendritic cell-like differentiation from monocytes to improve anticancer immune activity
02/09/2012US20120034245 Single-chain multivalent binding proteins with effector function
02/09/2012US20120034237 Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
02/09/2012US20120034231 Compositions and methods of use for therapeutic antibodies
02/09/2012US20120034230 Cna-B DOMAIN ANTIGENS IN VACCINES AGAINST GRAM POSITIVE BACTERIA
02/09/2012US20120034229 Monoclonal antibodies directed against lg4-5 domain of alpha3 chain of human laminin-5
02/09/2012US20120034228 CROSS-SPECIES-SPECIFIC PSCAxCD3, CD19xCD3, C-METxCD3, ENDOSIALINxCD3, EPCAMxCD3, IGF-1RxCD3 OR FAPALPHAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
02/09/2012US20120034227 Monoclonal antibody therapy for pancreas cancer
02/09/2012US20120034221 T-Cell Receptor Antibodies And Methods of Use Thereof
02/09/2012US20120034220 Mucin Fusion Polypeptide Vaccines, Compositions And Methods Of Use Thereof
02/09/2012US20120034215 Anti-mst1r antibodies and uses thereof
02/09/2012US20120034213 TREATMENT WITH ANTI-ErbB2 ANTIBODIES
02/09/2012US20120034212 Human Anti-IL-6 Antibodies With Extended In Vivo Half-Life And Their Use In Treatment Of Oncology, Autoimmune Diseases And Inflammatory Diseases
02/09/2012US20120034211 EGFR antibodies comprising modular recognition domains
02/09/2012US20120034196 Gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof (frank)
02/09/2012US20120034188 Akt Nucleic Acids, Polypeptides, and Uses Thereof
02/09/2012US20120034185 Anti-cd20 antibodies and fusion proteins therof and methods of use
02/09/2012US20120034167 Tyrosine kinase receptor tyro3 as a therapeutic target in the treatment of cancer
02/09/2012US20120034160 Dual variable domain immunoglobulins and uses thereof
02/09/2012DE102010039019A1 Antikörper gegen 6-sulfo LacNAc positive humane dendritische Zellen und deren Verwendung Antibodies against 6-sulfo LacNAc positive human dendritic cells and their use
02/09/2012DE102010039018A1 Anti-La Antikörper und ihre Anwendung zum Immunotargeting Anti-La antibodies and their application to Immunotargeting
02/09/2012DE102010039015A1 Linkerpeptid und seine Verwendung in Fusionsproteinen Linker peptide and its use in fusion proteins
02/09/2012DE102010038842A1 New aptamer that specifically binds to human tau protein or its fragment, useful e.g. in vitro for isolating, purifying and/or detecting tau protein, and to treat cerebral infarction, pick disease and/or progressive supranuclear palsy
02/09/2012CA2807749A1 Protein fusion constructs possessing thrombolytic and anticoagulant properties
02/09/2012CA2807552A1 Engineered nucleic acids and methods of use thereof
02/09/2012CA2807282A1 Mice that make binding proteins comprising vl domains
02/09/2012CA2807270A1 Method for targeted genomic events in algae
02/09/2012CA2807264A1 Genomics of actinoplanes utahensis
02/09/2012CA2807248A1 Highly multiplexed genotyping using leukoreduced blood samples
02/09/2012CA2807187A1 Antisense oligonucleotide directed removal of proteolytic cleavage sites from proteins
02/09/2012CA2807035A1 Mutated protoporphyrinogen ix oxidase (ppx) genes
02/09/2012CA2807014A1 Dual variable domain immunoglobulins and uses thereof
02/09/2012CA2806858A1 Reprogramming immortalized b cells
02/09/2012CA2806233A1 Transgenic animals and methods of use
02/09/2012CA2805265A1 Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina)
02/08/2012EP2415876A1 Highly sensitive detection method for highly virulent oral cavity bacteria
02/08/2012EP2415873A1 Optimized non-canonical zinc finger proteins
02/08/2012EP2415872A1 Optimized non-canonical zinc finger proteins
02/08/2012EP2415871A1 Polyion complex of double-stranded ribonucleic acid
02/08/2012EP2415870A1 Rnai molecule for thymidylate synthase and use thereof
02/08/2012EP2415869A1 Modified oligo-nucleic acid molecule, preparation method and uses thereof
1 ... 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 ... 4023